Single-Center, Randomized, Open, Exploratory, Drug Safety IIT Study of EE001 in Normal Adults/Patients with Mild, Moderate, or Severe (NYHA II-IV) Cardiac Insufficiency
Latest Information Update: 28 Mar 2025
At a glance
- Drugs EE-001 (Primary)
- Indications Heart failure
- Focus Adverse reactions; First in man
- Sponsors Anhui HygeianCells BioMedical
- 28 Mar 2025 New trial record